Literature DB >> 31747354

Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice.

David D Aguilar1, Robert E Strecker1, Radhika Basheer1, James M McNally1.   

Abstract

The type 5 metabotropic glutamate receptor (mGluR5) represents a novel therapeutic target for schizophrenia and other disorders. Schizophrenia is associated with progressive abnormalities in cortical oscillatory processes including reduced spindles (8-15 Hz) during sleep and increased delta (0.5-4 Hz)- and gamma-band activity (30-80 Hz) during wakefulness. mGluR5 knockout (KO) mice demonstrate many schizophrenia-like behaviors, including abnormal sleep. To examine the effects of mGluR5 on the maintenance of the neocortical circuitry responsible for such neural oscillations, we analyzed sleep/wake electroencephalographic (EEG) activity of mGluR5 KO mice at baseline, after 6 h of sleep deprivation, and during a visual method of cortical entrainment (visual steady state response). We hypothesized mGluR5-KO mice would exhibit translationally relevant abnormalities in sleep and neural oscillations that mimic schizophrenia. Power spectral and spindle density analyses were performed across 24-h EEG recordings in mGluR5-KO mice and wild-type (WT) controls. Novel findings in mGluR5 KO mice include deficits in sleep spindle density, wake alpha power, and 40-Hz visual task-evoked gamma power and phase locking. Sigma power (10-15 Hz), an approximation of spindle activity, was also reduced during non-rapid eye movement sleep transitions. Our observations on abnormal sleep/wake are generally in agreement with previous reports, although we did not replicate changes in rapid eye movement sleep. The timing of these phenotypes may suggest an impaired circadian process in mGluR5 KO mice. In conclusion, EEG phenotypes in mGluR5 KO mice resemble deficits observed in patients with schizophrenia. These findings implicate mGluR5-mediated pathways in several translationally relevant phenotypes associated with schizophrenia, and suggest that agents targeting this receptor may have harmful consequences on sleep health and daily patterns of EEG power.NEW & NOTEWORTHY Metabotropic glutamate receptor type 5 (mGluR5) knockout (KO) mice show several translationally relevant abnormalities in neural oscillatory activity associated with schizophrenia. These include deficits in sleep spindle density, sigma and alpha power, and 40-Hz task-evoked gamma power. The timing of these phenotypes suggests an impaired circadian process in these mice. Previously reported rapid eye movement sleep deficits in this model were not observed. These findings suggest mGluR5-enhancing drugs may improve sleep stability and sleep spindle density, which could impact memory and cognition.

Entities:  

Keywords:  N-methyl-d-aspartate receptors; metabotropic glutamate receptor 5; polysomnography; sigma; visual evoked potentials

Mesh:

Substances:

Year:  2019        PMID: 31747354      PMCID: PMC6985862          DOI: 10.1152/jn.00532.2019

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  68 in total

1.  Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex.

Authors:  E Chris Muly; Marcelia Maddox; Yoland Smith
Journal:  J Comp Neurol       Date:  2003-12-22       Impact factor: 3.215

2.  Aberrant EEG responses to gamma-frequency visual stimulation in schizophrenia.

Authors:  Igor Riečanský; Tomáš Kašpárek; Jitka Rehulová; Stanislav Katina; Radovan Přikryl
Journal:  Schizophr Res       Date:  2010-08-09       Impact factor: 4.939

3.  Maturational Patterns of Sigma Frequency Power Across Childhood and Adolescence: A Longitudinal Study.

Authors:  Ian G Campbell; Irwin Feinberg
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

4.  Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.

Authors:  David Elmenhorst; Kristina Mertens; Tina Kroll; Angela Oskamp; Johannes Ermert; Eva-Maria Elmenhorst; Franziska Wedekind; Simone Beer; Heinz H Coenen; Andreas Bauer
Journal:  J Sleep Res       Date:  2016-06-30       Impact factor: 3.981

5.  Spontaneous Gamma Activity in Schizophrenia.

Authors:  Yoji Hirano; Naoya Oribe; Shigenobu Kanba; Toshiaki Onitsuka; Paul G Nestor; Kevin M Spencer
Journal:  JAMA Psychiatry       Date:  2015-08       Impact factor: 21.596

6.  Negative symptoms and EEG alpha in schizophrenia: a replication.

Authors:  E L Merrin; T C Floyd
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

Review 7.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

Review 8.  Steady state responses: electrophysiological assessment of sensory function in schizophrenia.

Authors:  Colleen A Brenner; Giri P Krishnan; Jenifer L Vohs; Woo-Young Ahn; William P Hetrick; Sandra L Morzorati; Brian F O'Donnell
Journal:  Schizophr Bull       Date:  2009-09-02       Impact factor: 9.306

9.  The 40-Hz Auditory Steady-State Response in Patients With Schizophrenia: A Meta-analysis.

Authors:  Hanna Thuné; Marc Recasens; Peter J Uhlhaas
Journal:  JAMA Psychiatry       Date:  2016-11-01       Impact factor: 21.596

10.  Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages.

Authors:  Tineke Grent-'t-Jong; Joachim Gross; Jozien Goense; Michael Wibral; Ruchika Gajwani; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Tobias Navarro Schröder; Dagmar Koethe; F Markus Leweke; Wolf Singer; Peter J Uhlhaas
Journal:  Elife       Date:  2018-09-27       Impact factor: 8.140

View more
  9 in total

1.  Alterations in TRN-anterodorsal thalamocortical circuits affect sleep architecture and homeostatic processes in oxidative stress vulnerable Gclm-/- mice.

Authors:  Christina Czekus; Pascal Steullet; Albert Orero López; Ivan Bozic; Thomas Rusterholz; Mojtaba Bandarabadi; Kim Q Do; Carolina Gutierrez Herrera
Journal:  Mol Psychiatry       Date:  2022-07-28       Impact factor: 13.437

Review 2.  Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2022-03-03       Impact factor: 4.054

3.  Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms.

Authors:  James F Cavanagh; David Gregg; Gregory A Light; Sarah L Olguin; Richard F Sharp; Andrew W Bismark; Savita G Bhakta; Neal R Swerdlow; Jonathan L Brigman; Jared W Young
Journal:  Transl Psychiatry       Date:  2021-09-17       Impact factor: 7.989

4.  Analysis of the Gut Microbiota and Inflammatory Factors in mGluR5-Knockout Mice.

Authors:  Guohong Cai; Yuanyuan Zhu; Jing Chen; Suo Zhao; Liying Wang; Mengmeng Wang; Jing Huang; Shengxi Wu
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

5.  Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.

Authors:  N A Copping; J L Silverman
Journal:  Mol Autism       Date:  2021-02-06       Impact factor: 7.509

6.  Sleep-Wake Rhythm and Oscillatory Pattern Analysis in a Multiple Hit Schizophrenia Rat Model (Wisket).

Authors:  Leatitia Gabriella Adlan; Mátyás Csordás-Nagy; Balázs Bodosi; György Kalmár; László G Nyúl; Attila Nagy; Gabriella Kekesi; Alexandra Büki; Gyongyi Horvath
Journal:  Front Behav Neurosci       Date:  2022-01-28       Impact factor: 3.558

Review 7.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

8.  Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia.

Authors:  Carolina Gubert; Geraldine Kong; Volkan Uzungil; Ariel M Zeleznikow-Johnston; Emma L Burrows; Thibault Renoir; Anthony J Hannan
Journal:  Front Cell Dev Biol       Date:  2020-10-29

9.  Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG.

Authors:  Kimberly M Holter; Alex D Lekander; Christina M LaValley; Elizabeth G Bedingham; Bethany E Pierce; L Paul Sands; Craig W Lindsley; Carrie K Jones; Robert W Gould
Journal:  Front Neurosci       Date:  2021-07-02       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.